Trials / Sponsors / Shenzhen Celconta Life Science Co., Ltd.
Shenzhen Celconta Life Science Co., Ltd.
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | PANK-003 Cell Injection Combined With Standard Adjuvant Chemotherapy After Surgery in Patients With Stage IIIA Stage IIIA Non-small Cell Lung Cancer | Phase 2 | 2025-07-08 |
| Recruiting | Treating Claudin18.2-positive Advanced Solid Tumors with XKDCT225(Targeting Claudin18.2-CAR-T) Claudin18.2 Positive Advanced Solid Tumors | Phase 1 | 2025-01-01 |
| Unknown | Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T) Advanced Breast Cancer | Phase 1 | 2024-03-11 |
| Recruiting | PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumo Solid Tumors, Adult | Phase 1 | 2024-02-18 |